nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirtazapine—HTR2B—Sorafenib—thyroid cancer	0.163	0.32	CbGbCtD
Mirtazapine—HTR2C—Sorafenib—thyroid cancer	0.106	0.208	CbGbCtD
Mirtazapine—CYP2C8—Sorafenib—thyroid cancer	0.0498	0.0979	CbGbCtD
Mirtazapine—CYP1A2—Sorafenib—thyroid cancer	0.0386	0.0758	CbGbCtD
Mirtazapine—CYP2C9—Sorafenib—thyroid cancer	0.0348	0.0683	CbGbCtD
Mirtazapine—CYP3A4—Vandetanib—thyroid cancer	0.0335	0.0659	CbGbCtD
Mirtazapine—CYP2D6—Sorafenib—thyroid cancer	0.0318	0.0624	CbGbCtD
Mirtazapine—CYP3A4—Sorafenib—thyroid cancer	0.0202	0.0397	CbGbCtD
Mirtazapine—CYP2D6—Doxorubicin—thyroid cancer	0.0193	0.0379	CbGbCtD
Mirtazapine—CYP3A4—Doxorubicin—thyroid cancer	0.0123	0.0241	CbGbCtD
Mirtazapine—Asthenia—Sorafenib—thyroid cancer	0.000385	0.000994	CcSEcCtD
Mirtazapine—Mood swings—Epirubicin—thyroid cancer	0.000382	0.000987	CcSEcCtD
Mirtazapine—Lethargy—Doxorubicin—thyroid cancer	0.000381	0.000983	CcSEcCtD
Mirtazapine—Pruritus—Sorafenib—thyroid cancer	0.000379	0.00098	CcSEcCtD
Mirtazapine—Ataxia—Epirubicin—thyroid cancer	0.000379	0.000979	CcSEcCtD
Mirtazapine—Dehydration—Epirubicin—thyroid cancer	0.000375	0.000969	CcSEcCtD
Mirtazapine—Hyponatraemia—Doxorubicin—thyroid cancer	0.000375	0.000968	CcSEcCtD
Mirtazapine—Diplopia—Doxorubicin—thyroid cancer	0.000373	0.000964	CcSEcCtD
Mirtazapine—Osteoarthritis—Doxorubicin—thyroid cancer	0.000373	0.000964	CcSEcCtD
Mirtazapine—Liver function test abnormal—Epirubicin—thyroid cancer	0.000372	0.000962	CcSEcCtD
Mirtazapine—Dry skin—Epirubicin—thyroid cancer	0.00037	0.000955	CcSEcCtD
Mirtazapine—Orthostatic hypotension—Epirubicin—thyroid cancer	0.000368	0.000951	CcSEcCtD
Mirtazapine—Affect lability—Doxorubicin—thyroid cancer	0.000367	0.000949	CcSEcCtD
Mirtazapine—Migraine—Doxorubicin—thyroid cancer	0.000367	0.000949	CcSEcCtD
Mirtazapine—Diarrhoea—Sorafenib—thyroid cancer	0.000367	0.000948	CcSEcCtD
Mirtazapine—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.000363	0.000938	CcSEcCtD
Mirtazapine—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.000363	0.000938	CcSEcCtD
Mirtazapine—Face oedema—Doxorubicin—thyroid cancer	0.00036	0.00093	CcSEcCtD
Mirtazapine—Gastritis—Epirubicin—thyroid cancer	0.000357	0.000922	CcSEcCtD
Mirtazapine—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.000356	0.000919	CcSEcCtD
Mirtazapine—Muscular weakness—Epirubicin—thyroid cancer	0.000356	0.000919	CcSEcCtD
Mirtazapine—Dizziness—Sorafenib—thyroid cancer	0.000355	0.000916	CcSEcCtD
Mirtazapine—Mood swings—Doxorubicin—thyroid cancer	0.000353	0.000913	CcSEcCtD
Mirtazapine—Abdominal distension—Epirubicin—thyroid cancer	0.000351	0.000906	CcSEcCtD
Mirtazapine—Ataxia—Doxorubicin—thyroid cancer	0.000351	0.000906	CcSEcCtD
Mirtazapine—Influenza—Epirubicin—thyroid cancer	0.000348	0.0009	CcSEcCtD
Mirtazapine—Asthma—Epirubicin—thyroid cancer	0.000348	0.0009	CcSEcCtD
Mirtazapine—Dehydration—Doxorubicin—thyroid cancer	0.000347	0.000896	CcSEcCtD
Mirtazapine—Eosinophilia—Epirubicin—thyroid cancer	0.000345	0.000891	CcSEcCtD
Mirtazapine—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000344	0.00089	CcSEcCtD
Mirtazapine—Dry skin—Doxorubicin—thyroid cancer	0.000342	0.000883	CcSEcCtD
Mirtazapine—Pancreatitis—Epirubicin—thyroid cancer	0.000342	0.000883	CcSEcCtD
Mirtazapine—Vomiting—Sorafenib—thyroid cancer	0.000341	0.000881	CcSEcCtD
Mirtazapine—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.000341	0.00088	CcSEcCtD
Mirtazapine—Angina pectoris—Epirubicin—thyroid cancer	0.000339	0.000877	CcSEcCtD
Mirtazapine—Rash—Sorafenib—thyroid cancer	0.000338	0.000873	CcSEcCtD
Mirtazapine—Dermatitis—Sorafenib—thyroid cancer	0.000338	0.000873	CcSEcCtD
Mirtazapine—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.000336	0.000868	CcSEcCtD
Mirtazapine—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000336	0.000868	CcSEcCtD
Mirtazapine—Headache—Sorafenib—thyroid cancer	0.000336	0.000868	CcSEcCtD
Mirtazapine—Bronchitis—Epirubicin—thyroid cancer	0.000335	0.000866	CcSEcCtD
Mirtazapine—Pancytopenia—Epirubicin—thyroid cancer	0.000331	0.000855	CcSEcCtD
Mirtazapine—Gastritis—Doxorubicin—thyroid cancer	0.00033	0.000853	CcSEcCtD
Mirtazapine—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.000329	0.00085	CcSEcCtD
Mirtazapine—Muscular weakness—Doxorubicin—thyroid cancer	0.000329	0.00085	CcSEcCtD
Mirtazapine—Dysuria—Epirubicin—thyroid cancer	0.000326	0.000842	CcSEcCtD
Mirtazapine—Neutropenia—Epirubicin—thyroid cancer	0.000326	0.000842	CcSEcCtD
Mirtazapine—Abdominal distension—Doxorubicin—thyroid cancer	0.000325	0.000839	CcSEcCtD
Mirtazapine—Influenza—Doxorubicin—thyroid cancer	0.000322	0.000833	CcSEcCtD
Mirtazapine—Asthma—Doxorubicin—thyroid cancer	0.000322	0.000833	CcSEcCtD
Mirtazapine—Pollakiuria—Epirubicin—thyroid cancer	0.000322	0.000832	CcSEcCtD
Mirtazapine—Eosinophilia—Doxorubicin—thyroid cancer	0.000319	0.000825	CcSEcCtD
Mirtazapine—Nausea—Sorafenib—thyroid cancer	0.000318	0.000823	CcSEcCtD
Mirtazapine—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000318	0.000822	CcSEcCtD
Mirtazapine—Weight increased—Epirubicin—thyroid cancer	0.000317	0.000819	CcSEcCtD
Mirtazapine—Pancreatitis—Doxorubicin—thyroid cancer	0.000316	0.000817	CcSEcCtD
Mirtazapine—Weight decreased—Epirubicin—thyroid cancer	0.000315	0.000814	CcSEcCtD
Mirtazapine—Angina pectoris—Doxorubicin—thyroid cancer	0.000314	0.000811	CcSEcCtD
Mirtazapine—Pneumonia—Epirubicin—thyroid cancer	0.000313	0.000807	CcSEcCtD
Mirtazapine—Drowsiness—Epirubicin—thyroid cancer	0.000311	0.000803	CcSEcCtD
Mirtazapine—Bronchitis—Doxorubicin—thyroid cancer	0.00031	0.000801	CcSEcCtD
Mirtazapine—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000308	0.000796	CcSEcCtD
Mirtazapine—Pancytopenia—Doxorubicin—thyroid cancer	0.000306	0.000791	CcSEcCtD
Mirtazapine—Stomatitis—Epirubicin—thyroid cancer	0.000303	0.000782	CcSEcCtD
Mirtazapine—Jaundice—Epirubicin—thyroid cancer	0.000303	0.000782	CcSEcCtD
Mirtazapine—Urinary tract infection—Epirubicin—thyroid cancer	0.000302	0.00078	CcSEcCtD
Mirtazapine—Conjunctivitis—Epirubicin—thyroid cancer	0.000302	0.00078	CcSEcCtD
Mirtazapine—Neutropenia—Doxorubicin—thyroid cancer	0.000301	0.000779	CcSEcCtD
Mirtazapine—Dysuria—Doxorubicin—thyroid cancer	0.000301	0.000779	CcSEcCtD
Mirtazapine—Sweating—Epirubicin—thyroid cancer	0.000298	0.000769	CcSEcCtD
Mirtazapine—Pollakiuria—Doxorubicin—thyroid cancer	0.000298	0.000769	CcSEcCtD
Mirtazapine—Haematuria—Epirubicin—thyroid cancer	0.000296	0.000765	CcSEcCtD
Mirtazapine—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000294	0.00076	CcSEcCtD
Mirtazapine—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000294	0.000759	CcSEcCtD
Mirtazapine—Weight increased—Doxorubicin—thyroid cancer	0.000293	0.000758	CcSEcCtD
Mirtazapine—Epistaxis—Epirubicin—thyroid cancer	0.000293	0.000757	CcSEcCtD
Mirtazapine—Weight decreased—Doxorubicin—thyroid cancer	0.000292	0.000754	CcSEcCtD
Mirtazapine—Sinusitis—Epirubicin—thyroid cancer	0.000291	0.000753	CcSEcCtD
Mirtazapine—Agranulocytosis—Epirubicin—thyroid cancer	0.00029	0.000749	CcSEcCtD
Mirtazapine—Pneumonia—Doxorubicin—thyroid cancer	0.000289	0.000747	CcSEcCtD
Mirtazapine—Drowsiness—Doxorubicin—thyroid cancer	0.000287	0.000743	CcSEcCtD
Mirtazapine—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000285	0.000736	CcSEcCtD
Mirtazapine—Bradycardia—Epirubicin—thyroid cancer	0.000284	0.000734	CcSEcCtD
Mirtazapine—Jaundice—Doxorubicin—thyroid cancer	0.00028	0.000724	CcSEcCtD
Mirtazapine—Stomatitis—Doxorubicin—thyroid cancer	0.00028	0.000724	CcSEcCtD
Mirtazapine—Rhinitis—Epirubicin—thyroid cancer	0.00028	0.000722	CcSEcCtD
Mirtazapine—Conjunctivitis—Doxorubicin—thyroid cancer	0.000279	0.000722	CcSEcCtD
Mirtazapine—Urinary tract infection—Doxorubicin—thyroid cancer	0.000279	0.000722	CcSEcCtD
Mirtazapine—Hepatitis—Epirubicin—thyroid cancer	0.000279	0.000721	CcSEcCtD
Mirtazapine—Hypoaesthesia—Epirubicin—thyroid cancer	0.000278	0.000717	CcSEcCtD
Mirtazapine—Pharyngitis—Epirubicin—thyroid cancer	0.000277	0.000715	CcSEcCtD
Mirtazapine—Sweating—Doxorubicin—thyroid cancer	0.000276	0.000712	CcSEcCtD
Mirtazapine—Urinary tract disorder—Epirubicin—thyroid cancer	0.000275	0.000712	CcSEcCtD
Mirtazapine—Oedema peripheral—Epirubicin—thyroid cancer	0.000275	0.00071	CcSEcCtD
Mirtazapine—Haematuria—Doxorubicin—thyroid cancer	0.000274	0.000708	CcSEcCtD
Mirtazapine—Urethral disorder—Epirubicin—thyroid cancer	0.000273	0.000706	CcSEcCtD
Mirtazapine—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000272	0.000702	CcSEcCtD
Mirtazapine—Epistaxis—Doxorubicin—thyroid cancer	0.000271	0.0007	CcSEcCtD
Mirtazapine—Sinusitis—Doxorubicin—thyroid cancer	0.00027	0.000697	CcSEcCtD
Mirtazapine—Agranulocytosis—Doxorubicin—thyroid cancer	0.000268	0.000693	CcSEcCtD
Mirtazapine—Erythema multiforme—Epirubicin—thyroid cancer	0.000264	0.000681	CcSEcCtD
Mirtazapine—Bradycardia—Doxorubicin—thyroid cancer	0.000263	0.000679	CcSEcCtD
Mirtazapine—Eye disorder—Epirubicin—thyroid cancer	0.000261	0.000673	CcSEcCtD
Mirtazapine—Tinnitus—Epirubicin—thyroid cancer	0.00026	0.000672	CcSEcCtD
Mirtazapine—Cardiac disorder—Epirubicin—thyroid cancer	0.000259	0.000669	CcSEcCtD
Mirtazapine—Rhinitis—Doxorubicin—thyroid cancer	0.000259	0.000668	CcSEcCtD
Mirtazapine—Hepatitis—Doxorubicin—thyroid cancer	0.000258	0.000667	CcSEcCtD
Mirtazapine—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000257	0.000663	CcSEcCtD
Mirtazapine—Pharyngitis—Doxorubicin—thyroid cancer	0.000256	0.000662	CcSEcCtD
Mirtazapine—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000255	0.000658	CcSEcCtD
Mirtazapine—Oedema peripheral—Doxorubicin—thyroid cancer	0.000254	0.000657	CcSEcCtD
Mirtazapine—Angiopathy—Epirubicin—thyroid cancer	0.000253	0.000654	CcSEcCtD
Mirtazapine—Urethral disorder—Doxorubicin—thyroid cancer	0.000253	0.000654	CcSEcCtD
Mirtazapine—Chills—Epirubicin—thyroid cancer	0.00025	0.000646	CcSEcCtD
Mirtazapine—Arrhythmia—Epirubicin—thyroid cancer	0.000249	0.000644	CcSEcCtD
Mirtazapine—Alopecia—Epirubicin—thyroid cancer	0.000246	0.000637	CcSEcCtD
Mirtazapine—Mental disorder—Epirubicin—thyroid cancer	0.000244	0.000631	CcSEcCtD
Mirtazapine—Erythema multiforme—Doxorubicin—thyroid cancer	0.000244	0.00063	CcSEcCtD
Mirtazapine—Malnutrition—Epirubicin—thyroid cancer	0.000243	0.000627	CcSEcCtD
Mirtazapine—Eye disorder—Doxorubicin—thyroid cancer	0.000241	0.000623	CcSEcCtD
Mirtazapine—Tinnitus—Doxorubicin—thyroid cancer	0.000241	0.000622	CcSEcCtD
Mirtazapine—Cardiac disorder—Doxorubicin—thyroid cancer	0.00024	0.000619	CcSEcCtD
Mirtazapine—Flatulence—Epirubicin—thyroid cancer	0.000239	0.000618	CcSEcCtD
Mirtazapine—Tension—Epirubicin—thyroid cancer	0.000238	0.000615	CcSEcCtD
Mirtazapine—Dysgeusia—Epirubicin—thyroid cancer	0.000238	0.000614	CcSEcCtD
Mirtazapine—Nervousness—Epirubicin—thyroid cancer	0.000236	0.000609	CcSEcCtD
Mirtazapine—Back pain—Epirubicin—thyroid cancer	0.000235	0.000607	CcSEcCtD
Mirtazapine—Angiopathy—Doxorubicin—thyroid cancer	0.000234	0.000605	CcSEcCtD
Mirtazapine—Chills—Doxorubicin—thyroid cancer	0.000232	0.000598	CcSEcCtD
Mirtazapine—Arrhythmia—Doxorubicin—thyroid cancer	0.000231	0.000596	CcSEcCtD
Mirtazapine—Alopecia—Doxorubicin—thyroid cancer	0.000228	0.000589	CcSEcCtD
Mirtazapine—Mental disorder—Doxorubicin—thyroid cancer	0.000226	0.000584	CcSEcCtD
Mirtazapine—Ill-defined disorder—Epirubicin—thyroid cancer	0.000225	0.000582	CcSEcCtD
Mirtazapine—Malnutrition—Doxorubicin—thyroid cancer	0.000225	0.00058	CcSEcCtD
Mirtazapine—Anaemia—Epirubicin—thyroid cancer	0.000224	0.00058	CcSEcCtD
Mirtazapine—Agitation—Epirubicin—thyroid cancer	0.000223	0.000576	CcSEcCtD
Mirtazapine—Flatulence—Doxorubicin—thyroid cancer	0.000221	0.000572	CcSEcCtD
Mirtazapine—Tension—Doxorubicin—thyroid cancer	0.00022	0.00057	CcSEcCtD
Mirtazapine—Dysgeusia—Doxorubicin—thyroid cancer	0.00022	0.000568	CcSEcCtD
Mirtazapine—Malaise—Epirubicin—thyroid cancer	0.000219	0.000566	CcSEcCtD
Mirtazapine—Nervousness—Doxorubicin—thyroid cancer	0.000218	0.000564	CcSEcCtD
Mirtazapine—Vertigo—Epirubicin—thyroid cancer	0.000218	0.000564	CcSEcCtD
Mirtazapine—Syncope—Epirubicin—thyroid cancer	0.000218	0.000562	CcSEcCtD
Mirtazapine—Leukopenia—Epirubicin—thyroid cancer	0.000217	0.000561	CcSEcCtD
Mirtazapine—Back pain—Doxorubicin—thyroid cancer	0.000217	0.000561	CcSEcCtD
Mirtazapine—Palpitations—Epirubicin—thyroid cancer	0.000215	0.000554	CcSEcCtD
Mirtazapine—Loss of consciousness—Epirubicin—thyroid cancer	0.000213	0.000551	CcSEcCtD
Mirtazapine—Cough—Epirubicin—thyroid cancer	0.000212	0.000547	CcSEcCtD
Mirtazapine—Convulsion—Epirubicin—thyroid cancer	0.00021	0.000543	CcSEcCtD
Mirtazapine—Hypertension—Epirubicin—thyroid cancer	0.00021	0.000542	CcSEcCtD
Mirtazapine—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000208	0.000538	CcSEcCtD
Mirtazapine—Anaemia—Doxorubicin—thyroid cancer	0.000208	0.000536	CcSEcCtD
Mirtazapine—Arthralgia—Epirubicin—thyroid cancer	0.000207	0.000534	CcSEcCtD
Mirtazapine—Myalgia—Epirubicin—thyroid cancer	0.000207	0.000534	CcSEcCtD
Mirtazapine—Chest pain—Epirubicin—thyroid cancer	0.000207	0.000534	CcSEcCtD
Mirtazapine—Agitation—Doxorubicin—thyroid cancer	0.000206	0.000533	CcSEcCtD
Mirtazapine—Anxiety—Epirubicin—thyroid cancer	0.000206	0.000532	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000205	0.00053	CcSEcCtD
Mirtazapine—Discomfort—Epirubicin—thyroid cancer	0.000204	0.000528	CcSEcCtD
Mirtazapine—Malaise—Doxorubicin—thyroid cancer	0.000203	0.000523	CcSEcCtD
Mirtazapine—Dry mouth—Epirubicin—thyroid cancer	0.000202	0.000522	CcSEcCtD
Mirtazapine—Vertigo—Doxorubicin—thyroid cancer	0.000202	0.000521	CcSEcCtD
Mirtazapine—Syncope—Doxorubicin—thyroid cancer	0.000201	0.00052	CcSEcCtD
Mirtazapine—Leukopenia—Doxorubicin—thyroid cancer	0.000201	0.000519	CcSEcCtD
Mirtazapine—Confusional state—Epirubicin—thyroid cancer	0.0002	0.000516	CcSEcCtD
Mirtazapine—Palpitations—Doxorubicin—thyroid cancer	0.000199	0.000513	CcSEcCtD
Mirtazapine—Oedema—Epirubicin—thyroid cancer	0.000198	0.000512	CcSEcCtD
Mirtazapine—Loss of consciousness—Doxorubicin—thyroid cancer	0.000197	0.00051	CcSEcCtD
Mirtazapine—Infection—Epirubicin—thyroid cancer	0.000197	0.000509	CcSEcCtD
Mirtazapine—Cough—Doxorubicin—thyroid cancer	0.000196	0.000506	CcSEcCtD
Mirtazapine—Shock—Epirubicin—thyroid cancer	0.000195	0.000504	CcSEcCtD
Mirtazapine—Convulsion—Doxorubicin—thyroid cancer	0.000195	0.000503	CcSEcCtD
Mirtazapine—Nervous system disorder—Epirubicin—thyroid cancer	0.000194	0.000502	CcSEcCtD
Mirtazapine—Thrombocytopenia—Epirubicin—thyroid cancer	0.000194	0.000501	CcSEcCtD
Mirtazapine—Hypertension—Doxorubicin—thyroid cancer	0.000194	0.000501	CcSEcCtD
Mirtazapine—Tachycardia—Epirubicin—thyroid cancer	0.000193	0.0005	CcSEcCtD
Mirtazapine—Skin disorder—Epirubicin—thyroid cancer	0.000192	0.000497	CcSEcCtD
Mirtazapine—Hyperhidrosis—Epirubicin—thyroid cancer	0.000192	0.000495	CcSEcCtD
Mirtazapine—Chest pain—Doxorubicin—thyroid cancer	0.000191	0.000494	CcSEcCtD
Mirtazapine—Myalgia—Doxorubicin—thyroid cancer	0.000191	0.000494	CcSEcCtD
Mirtazapine—Arthralgia—Doxorubicin—thyroid cancer	0.000191	0.000494	CcSEcCtD
Mirtazapine—Anxiety—Doxorubicin—thyroid cancer	0.000191	0.000492	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.00019	0.000491	CcSEcCtD
Mirtazapine—Discomfort—Doxorubicin—thyroid cancer	0.000189	0.000488	CcSEcCtD
Mirtazapine—Anorexia—Epirubicin—thyroid cancer	0.000189	0.000488	CcSEcCtD
Mirtazapine—Dry mouth—Doxorubicin—thyroid cancer	0.000187	0.000483	CcSEcCtD
Mirtazapine—Hypotension—Epirubicin—thyroid cancer	0.000185	0.000478	CcSEcCtD
Mirtazapine—Confusional state—Doxorubicin—thyroid cancer	0.000185	0.000478	CcSEcCtD
Mirtazapine—Oedema—Doxorubicin—thyroid cancer	0.000183	0.000474	CcSEcCtD
Mirtazapine—Infection—Doxorubicin—thyroid cancer	0.000182	0.000471	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000181	0.000466	CcSEcCtD
Mirtazapine—Shock—Doxorubicin—thyroid cancer	0.00018	0.000466	CcSEcCtD
Mirtazapine—Nervous system disorder—Doxorubicin—thyroid cancer	0.00018	0.000464	CcSEcCtD
Mirtazapine—Thrombocytopenia—Doxorubicin—thyroid cancer	0.00018	0.000464	CcSEcCtD
Mirtazapine—Insomnia—Epirubicin—thyroid cancer	0.000179	0.000463	CcSEcCtD
Mirtazapine—Tachycardia—Doxorubicin—thyroid cancer	0.000179	0.000462	CcSEcCtD
Mirtazapine—Skin disorder—Doxorubicin—thyroid cancer	0.000178	0.00046	CcSEcCtD
Mirtazapine—Paraesthesia—Epirubicin—thyroid cancer	0.000178	0.00046	CcSEcCtD
Mirtazapine—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000177	0.000458	CcSEcCtD
Mirtazapine—Dyspnoea—Epirubicin—thyroid cancer	0.000177	0.000456	CcSEcCtD
Mirtazapine—Somnolence—Epirubicin—thyroid cancer	0.000176	0.000455	CcSEcCtD
Mirtazapine—Anorexia—Doxorubicin—thyroid cancer	0.000175	0.000451	CcSEcCtD
Mirtazapine—Dyspepsia—Epirubicin—thyroid cancer	0.000174	0.000451	CcSEcCtD
Mirtazapine—Decreased appetite—Epirubicin—thyroid cancer	0.000172	0.000445	CcSEcCtD
Mirtazapine—Hypotension—Doxorubicin—thyroid cancer	0.000171	0.000443	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000171	0.000442	CcSEcCtD
Mirtazapine—Fatigue—Epirubicin—thyroid cancer	0.000171	0.000441	CcSEcCtD
Mirtazapine—Pain—Epirubicin—thyroid cancer	0.000169	0.000438	CcSEcCtD
Mirtazapine—Constipation—Epirubicin—thyroid cancer	0.000169	0.000438	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000167	0.000432	CcSEcCtD
Mirtazapine—Insomnia—Doxorubicin—thyroid cancer	0.000166	0.000428	CcSEcCtD
Mirtazapine—Paraesthesia—Doxorubicin—thyroid cancer	0.000165	0.000425	CcSEcCtD
Mirtazapine—Dyspnoea—Doxorubicin—thyroid cancer	0.000163	0.000422	CcSEcCtD
Mirtazapine—Feeling abnormal—Epirubicin—thyroid cancer	0.000163	0.000422	CcSEcCtD
Mirtazapine—Somnolence—Doxorubicin—thyroid cancer	0.000163	0.000421	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000162	0.000419	CcSEcCtD
Mirtazapine—Dyspepsia—Doxorubicin—thyroid cancer	0.000161	0.000417	CcSEcCtD
Mirtazapine—Decreased appetite—Doxorubicin—thyroid cancer	0.000159	0.000412	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000158	0.000409	CcSEcCtD
Mirtazapine—Fatigue—Doxorubicin—thyroid cancer	0.000158	0.000408	CcSEcCtD
Mirtazapine—Urticaria—Epirubicin—thyroid cancer	0.000157	0.000407	CcSEcCtD
Mirtazapine—Pain—Doxorubicin—thyroid cancer	0.000157	0.000405	CcSEcCtD
Mirtazapine—Constipation—Doxorubicin—thyroid cancer	0.000157	0.000405	CcSEcCtD
Mirtazapine—Abdominal pain—Epirubicin—thyroid cancer	0.000157	0.000405	CcSEcCtD
Mirtazapine—Body temperature increased—Epirubicin—thyroid cancer	0.000157	0.000405	CcSEcCtD
Mirtazapine—Feeling abnormal—Doxorubicin—thyroid cancer	0.000151	0.00039	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.00015	0.000387	CcSEcCtD
Mirtazapine—Hypersensitivity—Epirubicin—thyroid cancer	0.000146	0.000377	CcSEcCtD
Mirtazapine—Urticaria—Doxorubicin—thyroid cancer	0.000146	0.000376	CcSEcCtD
Mirtazapine—Abdominal pain—Doxorubicin—thyroid cancer	0.000145	0.000374	CcSEcCtD
Mirtazapine—Body temperature increased—Doxorubicin—thyroid cancer	0.000145	0.000374	CcSEcCtD
Mirtazapine—Asthenia—Epirubicin—thyroid cancer	0.000142	0.000367	CcSEcCtD
Mirtazapine—Pruritus—Epirubicin—thyroid cancer	0.00014	0.000362	CcSEcCtD
Mirtazapine—Diarrhoea—Epirubicin—thyroid cancer	0.000136	0.00035	CcSEcCtD
Mirtazapine—Hypersensitivity—Doxorubicin—thyroid cancer	0.000135	0.000349	CcSEcCtD
Mirtazapine—Asthenia—Doxorubicin—thyroid cancer	0.000132	0.00034	CcSEcCtD
Mirtazapine—Dizziness—Epirubicin—thyroid cancer	0.000131	0.000339	CcSEcCtD
Mirtazapine—Pruritus—Doxorubicin—thyroid cancer	0.00013	0.000335	CcSEcCtD
Mirtazapine—Vomiting—Epirubicin—thyroid cancer	0.000126	0.000325	CcSEcCtD
Mirtazapine—Diarrhoea—Doxorubicin—thyroid cancer	0.000125	0.000324	CcSEcCtD
Mirtazapine—Rash—Epirubicin—thyroid cancer	0.000125	0.000323	CcSEcCtD
Mirtazapine—Dermatitis—Epirubicin—thyroid cancer	0.000125	0.000322	CcSEcCtD
Mirtazapine—Headache—Epirubicin—thyroid cancer	0.000124	0.000321	CcSEcCtD
Mirtazapine—Dizziness—Doxorubicin—thyroid cancer	0.000121	0.000313	CcSEcCtD
Mirtazapine—Nausea—Epirubicin—thyroid cancer	0.000118	0.000304	CcSEcCtD
Mirtazapine—Vomiting—Doxorubicin—thyroid cancer	0.000117	0.000301	CcSEcCtD
Mirtazapine—Rash—Doxorubicin—thyroid cancer	0.000116	0.000299	CcSEcCtD
Mirtazapine—Dermatitis—Doxorubicin—thyroid cancer	0.000116	0.000298	CcSEcCtD
Mirtazapine—Headache—Doxorubicin—thyroid cancer	0.000115	0.000297	CcSEcCtD
Mirtazapine—Nausea—Doxorubicin—thyroid cancer	0.000109	0.000281	CcSEcCtD
Mirtazapine—HRH3—head—thyroid cancer	8.47e-05	0.0816	CbGeAlD
Mirtazapine—HTR7—neck—thyroid cancer	6.22e-05	0.0599	CbGeAlD
Mirtazapine—DRD3—head—thyroid cancer	5.87e-05	0.0566	CbGeAlD
Mirtazapine—OPRK1—head—thyroid cancer	5.23e-05	0.0504	CbGeAlD
Mirtazapine—HTR3A—head—thyroid cancer	4.06e-05	0.0391	CbGeAlD
Mirtazapine—HTR2A—neck—thyroid cancer	3.88e-05	0.0374	CbGeAlD
Mirtazapine—HTR7—trachea—thyroid cancer	3.74e-05	0.0361	CbGeAlD
Mirtazapine—HTR2B—thyroid gland—thyroid cancer	3.46e-05	0.0333	CbGeAlD
Mirtazapine—ADRA2C—trachea—thyroid cancer	3.44e-05	0.0331	CbGeAlD
Mirtazapine—SLC6A3—head—thyroid cancer	3.38e-05	0.0326	CbGeAlD
Mirtazapine—HTR2C—head—thyroid cancer	3.27e-05	0.0315	CbGeAlD
Mirtazapine—ADRB1—head—thyroid cancer	3.21e-05	0.0309	CbGeAlD
Mirtazapine—SLC6A4—head—thyroid cancer	3.1e-05	0.0298	CbGeAlD
Mirtazapine—HTR2B—head—thyroid cancer	3.07e-05	0.0296	CbGeAlD
Mirtazapine—HRH1—trachea—thyroid cancer	2.8e-05	0.0269	CbGeAlD
Mirtazapine—HTR1A—head—thyroid cancer	2.75e-05	0.0265	CbGeAlD
Mirtazapine—ADRA2A—trachea—thyroid cancer	2.75e-05	0.0265	CbGeAlD
Mirtazapine—SLC6A2—head—thyroid cancer	2.73e-05	0.0263	CbGeAlD
Mirtazapine—HTR7—head—thyroid cancer	2.63e-05	0.0253	CbGeAlD
Mirtazapine—ADRA1A—head—thyroid cancer	2.53e-05	0.0244	CbGeAlD
Mirtazapine—DRD2—head—thyroid cancer	2.48e-05	0.0239	CbGeAlD
Mirtazapine—ADRA2C—head—thyroid cancer	2.42e-05	0.0233	CbGeAlD
Mirtazapine—CYP1A2—thyroid gland—thyroid cancer	2.36e-05	0.0228	CbGeAlD
Mirtazapine—HTR2A—trachea—thyroid cancer	2.34e-05	0.0225	CbGeAlD
Mirtazapine—ADRA2A—thyroid gland—thyroid cancer	2.17e-05	0.0209	CbGeAlD
Mirtazapine—HTR2B—lymph node—thyroid cancer	2.15e-05	0.0207	CbGeAlD
Mirtazapine—HRH1—head—thyroid cancer	1.96e-05	0.0189	CbGeAlD
Mirtazapine—ADRA2A—head—thyroid cancer	1.93e-05	0.0186	CbGeAlD
Mirtazapine—SLC6A2—lymph node—thyroid cancer	1.91e-05	0.0184	CbGeAlD
Mirtazapine—HRH1—Signaling Pathways—NRG1—thyroid cancer	1.91e-05	0.000186	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—HIF1A—thyroid cancer	1.9e-05	0.000185	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—HIF1A—thyroid cancer	1.89e-05	0.000184	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—HRAS—thyroid cancer	1.89e-05	0.000184	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.88e-05	0.000183	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—NRG1—thyroid cancer	1.87e-05	0.000182	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—PPARG—thyroid cancer	1.87e-05	0.000182	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—SLC5A5—thyroid cancer	1.87e-05	0.000182	CbGpPWpGaD
Mirtazapine—DRD4—Signaling by GPCR—KRAS—thyroid cancer	1.86e-05	0.000181	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.86e-05	0.000181	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—SLC5A5—thyroid cancer	1.85e-05	0.00018	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—HIF1A—thyroid cancer	1.84e-05	0.000179	CbGpPWpGaD
Mirtazapine—ADRA2C—Hemostasis—AKT1—thyroid cancer	1.82e-05	0.000178	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—BRAF—thyroid cancer	1.81e-05	0.000176	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling by GPCR—KRAS—thyroid cancer	1.78e-05	0.000173	CbGpPWpGaD
Mirtazapine—ADRA2A—Hemostasis—TP53—thyroid cancer	1.75e-05	0.000171	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—NRAS—thyroid cancer	1.75e-05	0.000171	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—TERT—thyroid cancer	1.74e-05	0.00017	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—NRG1—thyroid cancer	1.74e-05	0.00017	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.73e-05	0.000169	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—TERT—thyroid cancer	1.72e-05	0.000167	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—TERT—thyroid cancer	1.71e-05	0.000167	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—NRAS—thyroid cancer	1.71e-05	0.000167	CbGpPWpGaD
Mirtazapine—ADRA2C—lymph node—thyroid cancer	1.69e-05	0.0163	CbGeAlD
Mirtazapine—ADRA1A—Signaling Pathways—TERT—thyroid cancer	1.68e-05	0.000164	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling by GPCR—HRAS—thyroid cancer	1.68e-05	0.000164	CbGpPWpGaD
Mirtazapine—ADRA2A—Hemostasis—HRAS—thyroid cancer	1.68e-05	0.000163	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—NRAS—thyroid cancer	1.67e-05	0.000163	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—HIF1A—thyroid cancer	1.67e-05	0.000163	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—AKT1—thyroid cancer	1.67e-05	0.000162	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—NRAS—thyroid cancer	1.67e-05	0.000162	CbGpPWpGaD
Mirtazapine—DRD3—Signaling by GPCR—KRAS—thyroid cancer	1.65e-05	0.000161	CbGpPWpGaD
Mirtazapine—HTR7—Signaling by GPCR—HRAS—thyroid cancer	1.65e-05	0.000161	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—BRAF—thyroid cancer	1.65e-05	0.00016	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—HIF1A—thyroid cancer	1.64e-05	0.00016	CbGpPWpGaD
Mirtazapine—HTR2A—head—thyroid cancer	1.64e-05	0.0158	CbGeAlD
Mirtazapine—HRH1—Signaling Pathways—HIF1A—thyroid cancer	1.64e-05	0.00016	CbGpPWpGaD
Mirtazapine—OPRK1—GPCR downstream signaling—AKT1—thyroid cancer	1.63e-05	0.000159	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—TPR—thyroid cancer	1.63e-05	0.000159	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—NRAS—thyroid cancer	1.62e-05	0.000158	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—BRAF—thyroid cancer	1.61e-05	0.000157	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—HIF1A—thyroid cancer	1.61e-05	0.000157	CbGpPWpGaD
Mirtazapine—HTR7—GPCR downstream signaling—AKT1—thyroid cancer	1.61e-05	0.000157	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	1.6e-05	0.000156	CbGpPWpGaD
Mirtazapine—DRD4—Signaling by GPCR—HRAS—thyroid cancer	1.58e-05	0.000154	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—SLC5A5—thyroid cancer	1.58e-05	0.000154	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—CCND1—thyroid cancer	1.57e-05	0.000153	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—BRAF—thyroid cancer	1.57e-05	0.000153	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—RXRA—thyroid cancer	1.57e-05	0.000153	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—BRAF—thyroid cancer	1.57e-05	0.000153	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—TERT—thyroid cancer	1.56e-05	0.000152	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—RXRA—thyroid cancer	1.55e-05	0.000151	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—CCND1—thyroid cancer	1.55e-05	0.000151	CbGpPWpGaD
Mirtazapine—DRD4—GPCR downstream signaling—AKT1—thyroid cancer	1.54e-05	0.00015	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—BRAF—thyroid cancer	1.52e-05	0.000148	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—PTEN—thyroid cancer	1.52e-05	0.000148	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—PPARG—thyroid cancer	1.52e-05	0.000148	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.51e-05	0.000147	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling by GPCR—HRAS—thyroid cancer	1.51e-05	0.000147	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—KRAS—thyroid cancer	1.51e-05	0.000147	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—PTEN—thyroid cancer	1.5e-05	0.000146	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—HIF1A—thyroid cancer	1.49e-05	0.000146	CbGpPWpGaD
Mirtazapine—CYP2D6—head—thyroid cancer	1.49e-05	0.0144	CbGeAlD
Mirtazapine—DRD4—Signaling Pathways—CCND1—thyroid cancer	1.48e-05	0.000145	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling by GPCR—AKT1—thyroid cancer	1.48e-05	0.000144	CbGpPWpGaD
Mirtazapine—ADRA2A—Hemostasis—AKT1—thyroid cancer	1.48e-05	0.000144	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.48e-05	0.000144	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—KRAS—thyroid cancer	1.47e-05	0.000144	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—PTGS2—thyroid cancer	1.47e-05	0.000143	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—NRAS—thyroid cancer	1.47e-05	0.000143	CbGpPWpGaD
Mirtazapine—HTR2B—GPCR downstream signaling—AKT1—thyroid cancer	1.47e-05	0.000143	CbGpPWpGaD
Mirtazapine—HTR7—Signaling by GPCR—AKT1—thyroid cancer	1.46e-05	0.000142	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—NRAS—thyroid cancer	1.45e-05	0.000141	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—NRAS—thyroid cancer	1.44e-05	0.000141	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—KRAS—thyroid cancer	1.44e-05	0.00014	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—KRAS—thyroid cancer	1.43e-05	0.00014	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—PTEN—thyroid cancer	1.43e-05	0.00014	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—CCND1—thyroid cancer	1.42e-05	0.000138	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—NRAS—thyroid cancer	1.42e-05	0.000138	CbGpPWpGaD
Mirtazapine—DRD3—Signaling by GPCR—HRAS—thyroid cancer	1.41e-05	0.000137	CbGpPWpGaD
Mirtazapine—DRD4—Signaling by GPCR—AKT1—thyroid cancer	1.4e-05	0.000136	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—KRAS—thyroid cancer	1.39e-05	0.000136	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—BRAF—thyroid cancer	1.38e-05	0.000135	CbGpPWpGaD
Mirtazapine—HRH1—lymph node—thyroid cancer	1.37e-05	0.0132	CbGeAlD
Mirtazapine—HTR2B—Signaling Pathways—PTEN—thyroid cancer	1.37e-05	0.000133	CbGpPWpGaD
Mirtazapine—DRD3—GPCR downstream signaling—AKT1—thyroid cancer	1.37e-05	0.000133	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—BRAF—thyroid cancer	1.36e-05	0.000132	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—BRAF—thyroid cancer	1.36e-05	0.000132	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—NRAS—thyroid cancer	1.36e-05	0.000132	CbGpPWpGaD
Mirtazapine—ADRA2A—lymph node—thyroid cancer	1.35e-05	0.013	CbGeAlD
Mirtazapine—HTR7—Signaling Pathways—NRAS—thyroid cancer	1.33e-05	0.00013	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling by GPCR—AKT1—thyroid cancer	1.33e-05	0.00013	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—BRAF—thyroid cancer	1.33e-05	0.00013	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—RXRA—thyroid cancer	1.33e-05	0.000129	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—CCND1—thyroid cancer	1.32e-05	0.000128	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—NRAS—thyroid cancer	1.32e-05	0.000128	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.29e-05	0.000126	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—PTEN—thyroid cancer	1.28e-05	0.000125	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—HRAS—thyroid cancer	1.28e-05	0.000125	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—NRAS—thyroid cancer	1.28e-05	0.000125	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—PTEN—thyroid cancer	1.27e-05	0.000124	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—KRAS—thyroid cancer	1.27e-05	0.000123	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—HRAS—thyroid cancer	1.25e-05	0.000122	CbGpPWpGaD
Mirtazapine—ADRB1—GPCR downstream signaling—AKT1—thyroid cancer	1.25e-05	0.000121	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—KRAS—thyroid cancer	1.24e-05	0.000121	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—KRAS—thyroid cancer	1.24e-05	0.000121	CbGpPWpGaD
Mirtazapine—DRD3—Signaling by GPCR—AKT1—thyroid cancer	1.24e-05	0.000121	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—BRAF—thyroid cancer	1.24e-05	0.000121	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—HRAS—thyroid cancer	1.22e-05	0.000119	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—SLC5A5—thyroid cancer	1.22e-05	0.000119	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—NRAS—thyroid cancer	1.22e-05	0.000119	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—KRAS—thyroid cancer	1.22e-05	0.000119	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—HRAS—thyroid cancer	1.22e-05	0.000119	CbGpPWpGaD
Mirtazapine—ADRB2—GPCR downstream signaling—AKT1—thyroid cancer	1.22e-05	0.000119	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PPARG—thyroid cancer	1.21e-05	0.000117	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—CCND1—thyroid cancer	1.2e-05	0.000117	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—PTGS2—thyroid cancer	1.19e-05	0.000116	CbGpPWpGaD
Mirtazapine—HTR1A—GPCR downstream signaling—AKT1—thyroid cancer	1.19e-05	0.000116	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—HRAS—thyroid cancer	1.19e-05	0.000116	CbGpPWpGaD
Mirtazapine—HTR2C—GPCR downstream signaling—AKT1—thyroid cancer	1.18e-05	0.000115	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—CCND1—thyroid cancer	1.17e-05	0.000114	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—KRAS—thyroid cancer	1.17e-05	0.000114	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—PTEN—thyroid cancer	1.16e-05	0.000113	CbGpPWpGaD
Mirtazapine—ADRA2C—GPCR downstream signaling—AKT1—thyroid cancer	1.15e-05	0.000112	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—KRAS—thyroid cancer	1.15e-05	0.000112	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—CCND1—thyroid cancer	1.15e-05	0.000112	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—CCND1—thyroid cancer	1.14e-05	0.000111	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—NRAS—thyroid cancer	1.13e-05	0.000111	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—PTEN—thyroid cancer	1.13e-05	0.00011	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—KRAS—thyroid cancer	1.13e-05	0.00011	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—AKT1—thyroid cancer	1.13e-05	0.00011	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—CCND1—thyroid cancer	1.11e-05	0.000108	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—PTEN—thyroid cancer	1.11e-05	0.000108	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—AKT1—thyroid cancer	1.11e-05	0.000108	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—PTEN—thyroid cancer	1.1e-05	0.000107	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—KRAS—thyroid cancer	1.1e-05	0.000107	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—AKT1—thyroid cancer	1.08e-05	0.000105	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—AKT1—thyroid cancer	1.08e-05	0.000105	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—HRAS—thyroid cancer	1.08e-05	0.000105	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—PTEN—thyroid cancer	1.07e-05	0.000105	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—HRAS—thyroid cancer	1.06e-05	0.000103	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—HRAS—thyroid cancer	1.06e-05	0.000103	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—KRAS—thyroid cancer	1.05e-05	0.000102	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—AKT1—thyroid cancer	1.05e-05	0.000102	CbGpPWpGaD
Mirtazapine—DRD2—GPCR downstream signaling—AKT1—thyroid cancer	1.05e-05	0.000102	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—PTEN—thyroid cancer	1.04e-05	0.000102	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—TP53—thyroid cancer	1.04e-05	0.000101	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—HRAS—thyroid cancer	1.04e-05	0.000101	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—NRAS—thyroid cancer	1.03e-05	0.000101	CbGpPWpGaD
Mirtazapine—HTR2A—GPCR downstream signaling—AKT1—thyroid cancer	1.03e-05	0.0001	CbGpPWpGaD
Mirtazapine—HRH1—GPCR downstream signaling—AKT1—thyroid cancer	1.03e-05	0.0001	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—RXRA—thyroid cancer	1.02e-05	9.99e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—TP53—thyroid cancer	1.02e-05	9.95e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—NRAS—thyroid cancer	1.01e-05	9.86e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CCND1—thyroid cancer	1.01e-05	9.83e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR downstream signaling—AKT1—thyroid cancer	1.01e-05	9.82e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CCND1—thyroid cancer	9.92e-06	9.67e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—HRAS—thyroid cancer	9.92e-06	9.67e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CCND1—thyroid cancer	9.9e-06	9.65e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PPARG—thyroid cancer	9.9e-06	9.65e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—NRAS—thyroid cancer	9.89e-06	9.64e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—NRAS—thyroid cancer	9.84e-06	9.59e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PPARG—thyroid cancer	9.81e-06	9.56e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—TP53—thyroid cancer	9.77e-06	9.52e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—KRAS—thyroid cancer	9.77e-06	9.52e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—HRAS—thyroid cancer	9.76e-06	9.52e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—PTEN—thyroid cancer	9.73e-06	9.49e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CCND1—thyroid cancer	9.72e-06	9.47e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—HRAS—thyroid cancer	9.63e-06	9.38e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—PTEN—thyroid cancer	9.58e-06	9.33e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—NRAS—thyroid cancer	9.57e-06	9.33e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—PTEN—thyroid cancer	9.56e-06	9.31e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—AKT1—thyroid cancer	9.5e-06	9.25e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PTGS2—thyroid cancer	9.48e-06	9.24e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—PTEN—thyroid cancer	9.38e-06	9.14e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—AKT1—thyroid cancer	9.36e-06	9.12e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—HRAS—thyroid cancer	9.35e-06	9.11e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—AKT1—thyroid cancer	9.34e-06	9.11e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—TP53—thyroid cancer	9.33e-06	9.09e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—AKT1—thyroid cancer	9.32e-06	9.09e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—AKT1—thyroid cancer	9.15e-06	8.92e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CCND1—thyroid cancer	9.03e-06	8.8e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—HRAS—thyroid cancer	8.92e-06	8.7e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—KRAS—thyroid cancer	8.9e-06	8.67e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—AKT1—thyroid cancer	8.76e-06	8.53e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—PTEN—thyroid cancer	8.71e-06	8.49e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—KRAS—thyroid cancer	8.71e-06	8.48e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—NRAS—thyroid cancer	8.68e-06	8.46e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—TP53—thyroid cancer	8.68e-06	8.46e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—AKT1—thyroid cancer	8.62e-06	8.4e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—NRAS—thyroid cancer	8.54e-06	8.33e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—NRAS—thyroid cancer	8.53e-06	8.31e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—KRAS—thyroid cancer	8.51e-06	8.3e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—AKT1—thyroid cancer	8.5e-06	8.28e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—KRAS—thyroid cancer	8.47e-06	8.25e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PPARG—thyroid cancer	8.38e-06	8.17e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—NRAS—thyroid cancer	8.37e-06	8.15e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—HRAS—thyroid cancer	8.3e-06	8.09e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PTEN—thyroid cancer	8.27e-06	8.06e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—AKT1—thyroid cancer	8.25e-06	8.04e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—KRAS—thyroid cancer	8.24e-06	8.03e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—TP53—thyroid cancer	7.91e-06	7.71e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—AKT1—thyroid cancer	7.88e-06	7.68e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PTGS2—thyroid cancer	7.79e-06	7.59e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—NRAS—thyroid cancer	7.77e-06	7.58e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—TP53—thyroid cancer	7.74e-06	7.54e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PTGS2—thyroid cancer	7.72e-06	7.52e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—TP53—thyroid cancer	7.57e-06	7.37e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—HRAS—thyroid cancer	7.56e-06	7.37e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—TP53—thyroid cancer	7.53e-06	7.34e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—KRAS—thyroid cancer	7.47e-06	7.28e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—HRAS—thyroid cancer	7.4e-06	7.21e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—AKT1—thyroid cancer	7.39e-06	7.21e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—KRAS—thyroid cancer	7.35e-06	7.17e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—KRAS—thyroid cancer	7.34e-06	7.15e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—AKT1—thyroid cancer	7.33e-06	7.14e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—TP53—thyroid cancer	7.32e-06	7.13e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—HRAS—thyroid cancer	7.24e-06	7.05e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—KRAS—thyroid cancer	7.2e-06	7.02e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—HRAS—thyroid cancer	7.2e-06	7.02e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—HRAS—thyroid cancer	7e-06	6.82e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PTEN—thyroid cancer	6.79e-06	6.62e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PTEN—thyroid cancer	6.73e-06	6.56e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—KRAS—thyroid cancer	6.69e-06	6.52e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—AKT1—thyroid cancer	6.68e-06	6.51e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—TP53—thyroid cancer	6.64e-06	6.47e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PTGS2—thyroid cancer	6.6e-06	6.43e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—TP53—thyroid cancer	6.54e-06	6.37e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—AKT1—thyroid cancer	6.53e-06	6.37e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—TP53—thyroid cancer	6.52e-06	6.36e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PPARG—thyroid cancer	6.47e-06	6.31e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—TP53—thyroid cancer	6.4e-06	6.24e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—AKT1—thyroid cancer	6.39e-06	6.23e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—AKT1—thyroid cancer	6.36e-06	6.19e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—HRAS—thyroid cancer	6.35e-06	6.19e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—HRAS—thyroid cancer	6.25e-06	6.09e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—HRAS—thyroid cancer	6.24e-06	6.08e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—AKT1—thyroid cancer	6.18e-06	6.02e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—HRAS—thyroid cancer	6.12e-06	5.96e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—AKT1—thyroid cancer	6.01e-06	5.85e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—TP53—thyroid cancer	5.95e-06	5.79e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PTEN—thyroid cancer	5.75e-06	5.61e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—HRAS—thyroid cancer	5.69e-06	5.54e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—AKT1—thyroid cancer	5.61e-06	5.47e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—AKT1—thyroid cancer	5.52e-06	5.38e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—AKT1—thyroid cancer	5.51e-06	5.37e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—AKT1—thyroid cancer	5.4e-06	5.27e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PTGS2—thyroid cancer	5.09e-06	4.96e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—AKT1—thyroid cancer	5.02e-06	4.89e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—AKT1—thyroid cancer	4.77e-06	4.65e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PTEN—thyroid cancer	4.44e-06	4.33e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—AKT1—thyroid cancer	3.91e-06	3.81e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—AKT1—thyroid cancer	3.88e-06	3.78e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—AKT1—thyroid cancer	3.32e-06	3.23e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—AKT1—thyroid cancer	2.56e-06	2.49e-05	CbGpPWpGaD
